223 related articles for article (PubMed ID: 32304100)
1. Statin and cyclooxygenase-2 inhibitors improve survival in newly diagnosed diffuse large B-cell lymphoma: a large population-based study of 4913 subjects.
Smyth L; Blunt DN; Gatov E; Nagamuthu C; Croxford R; Mozessohn L; Cheung MC
Br J Haematol; 2020 Nov; 191(3):396-404. PubMed ID: 32304100
[TBL] [Abstract][Full Text] [Related]
2. Statin use and prognosis in patients with diffuse large B-cell lymphoma and follicular lymphoma in the rituximab era.
Nowakowski GS; Maurer MJ; Habermann TM; Ansell SM; Macon WR; Ristow KM; Allmer C; Slager SL; Witzig TE; Cerhan JR
J Clin Oncol; 2010 Jan; 28(3):412-7. PubMed ID: 20008638
[TBL] [Abstract][Full Text] [Related]
3. Shorter Diagnosis-to-Treatment Interval in Diffuse Large B-Cell Lymphoma is Associated With Inferior Overall Survival in a Large, Population-Based Registry.
Blunt DN; Smyth L; Nagamuthu C; Gatov E; Croxford R; Mozessohn L; Cheung MC
J Natl Compr Canc Netw; 2021 Mar; 19(6):719-725. PubMed ID: 33691276
[TBL] [Abstract][Full Text] [Related]
4. Concomitant statin use does not impair the clinical outcome of patients with diffuse large B cell lymphoma treated with rituximab-CHOP.
Samaras P; Heider H; Haile SR; Petrausch U; Schaefer NG; Siciliano RD; Meisel A; Mischo A; Zweifel M; Knuth A; Stenner-Liewen F; Renner C
Ann Hematol; 2010 Aug; 89(8):783-7. PubMed ID: 20204361
[TBL] [Abstract][Full Text] [Related]
5. Statin use has negative clinical impact on non-germinal center in patients with diffuse large B cell lymphoma in rituximab era.
Song MK; Chung JS; Lee GW; Cho SH; Hong J; Shin DY; Shin HJ
Leuk Res; 2015 Feb; 39(2):211-5. PubMed ID: 25541029
[TBL] [Abstract][Full Text] [Related]
6. Statin-independent prognosis of patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy.
Ennishi D; Asai H; Maeda Y; Shinagawa K; Ikeda K; Yokoyama M; Terui Y; Takeuchi K; Yoshino T; Matsuo K; Hatake K; Tanimoto M
Ann Oncol; 2010 Jun; 21(6):1217-1221. PubMed ID: 19884246
[TBL] [Abstract][Full Text] [Related]
7. Effect of concomitant statin, metformin, or aspirin on rituximab treatment for diffuse large B-cell lymphoma.
Koo YX; Tan DS; Tan IB; Tai DW; Ha T; Ong WS; Quek R; Tao M; Lim ST
Leuk Lymphoma; 2011 Aug; 52(8):1509-16. PubMed ID: 21651435
[TBL] [Abstract][Full Text] [Related]
8. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
[TBL] [Abstract][Full Text] [Related]
9. Statin use and its effect on all-cause mortality of melanoma patients: a population-based Dutch cohort study.
Livingstone E; Hollestein LM; van Herk-Sukel MP; van de Poll-Franse L; Joosse A; Schilling B; Nijsten T; Schadendorf D; de Vries E
Cancer Med; 2014 Oct; 3(5):1284-93. PubMed ID: 24935402
[TBL] [Abstract][Full Text] [Related]
10. An analysis of the effect of statins on the risk of Non-Hodgkin's Lymphoma in the Women's Health Initiative cohort.
Desai P; Wallace R; Anderson ML; Howard BV; Ray R; Wu C; Safford M; Martin LW; Schlecht N; Liu S; Cirillo D; Jay A; Manson JE; Simon MS
Cancer Med; 2018 May; 7(5):2121-2130. PubMed ID: 29608241
[TBL] [Abstract][Full Text] [Related]
11. Influence of Statins on the Survival Outcomes of Patients with Diffuse Large B Cell Lymphoma: A Systematic Review and Meta-Analysis.
Li Y; Zhou H; Zou L
Int J Clin Pract; 2022; 2022():5618290. PubMed ID: 35989867
[TBL] [Abstract][Full Text] [Related]
12. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab.
Gundrum JD; Mathiason MA; Moore DB; Go RS
J Clin Oncol; 2009 Nov; 27(31):5227-32. PubMed ID: 19770371
[TBL] [Abstract][Full Text] [Related]
13. Frailty in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Receiving Curative-Intent Therapy: A Population-Based Study.
Vijenthira A; Mozessohn L; Nagamuthu C; Liu N; Blunt D; Alibhai S; Prica A; Cheung MC
J Natl Compr Canc Netw; 2022 Jun; 20(6):635-642.e9. PubMed ID: 35714676
[TBL] [Abstract][Full Text] [Related]
14. Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.
Belotti A; Doni E; Bolis S; Rossini F; Casaroli I; Pezzatti S; Pogliani EM; Pioltelli PE
Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):208-13. PubMed ID: 25468321
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].
Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ
Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579
[No Abstract] [Full Text] [Related]
16. Season of diagnosis is associated with overall survival in patients with diffuse large B-cell lymphoma but not with Hodgkin's lymphoma - A population-based Swedish Lymphoma Register study.
Székely E; Lindén O; Peterson S; Jerkeman M
Eur J Haematol; 2016 Oct; 97(4):393-8. PubMed ID: 26872557
[TBL] [Abstract][Full Text] [Related]
17. Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B-cell lymphoma: a Swedish lymphoma register study.
Wästerlid T; Mohammadi M; Smedby KE; Glimelius I; Jerkeman M; Bottai M; Eloranta S
J Intern Med; 2019 Apr; 285(4):455-468. PubMed ID: 30368947
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness and cost of adding rituximab to first-line chemotherapy for elderly patients diagnosed with diffuse large B-cell lymphoma.
Griffiths RI; Gleeson ML; Mikhael J; Dreyling MH; Danese MD
Cancer; 2012 Dec; 118(24):6079-88. PubMed ID: 22648454
[TBL] [Abstract][Full Text] [Related]
19. Treatment Modalities and Survival Outcomes for Sinonasal Diffuse Large B-Cell Lymphoma.
Lehrich BM; Abiri A; Goshtasbi K; Birkenbeuel J; Yasaka TM; Papagiannopoulos P; Tajudeen BA; Brem EA; Kuan EC
Laryngoscope; 2021 Nov; 131(11):E2727-E2735. PubMed ID: 33899946
[TBL] [Abstract][Full Text] [Related]
20. Statin use and survival in 16 098 patients with non-Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era.
Brånvall E; Ekberg S; Eloranta S; Wästerlid T; Birmann BM; Smedby KE
Br J Haematol; 2021 Nov; 195(4):552-560. PubMed ID: 34331461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
